Events

NEWS & EVENTS

SEE WHAT’S NEW AT QRITIVE—FROM BREAKTHROUGH STUDIES TO STRATEGIC COLLABORATIONS AND EVENT SHOWCASES.

Stay up to date with Qritive’s latest news, events, and announcements as we advance the future of digital pathology through global collaboration, scientific innovation, and clinical milestones.

Qritive at USCAP 2025: Presenting AI-Powered Study on Lymph Node Metastasis Detection

Singapore, April 1, 2025 — Qritive participated in the United States and Canadian Academy of Pathology (USCAP) 2025 Annual Meeting, held...

Events

Apr 2

Transforming Laboratory Diagnostics with AI – Qritive at Medlab Middle East 2025

Singapore, February 10, 2025 — Qritive participated in Medlab Middle East 2025, held from February 3–5 at the Dubai World Trade Centre,...

Events

Feb 10

Enhancing Prostate Cancer Diagnosis with AI – Insights from the Uro-oncology Congress

Singapore, January 17, 2025 — Qritive participated in the International Congress on Frontiers in Urologic Oncology and Uropathology,...

Events

Jan 17

Driving AI Adoption in Pathology Across Europe – Highlights from the 11th Congress

Singapore, December 17, 2024 — Qritive participated in the 11th Digital Pathology & AI Congress: Europe, held on 11–12 December 2024 in...

Events

Dec 18, 2024

Qritive Pte. Ltd. is now ISO/IEC 27001:2022 certified

This certification is a testament to our commitment to maintaining the highest standards of information security management. It...

News

Jul 10, 2024

Qritive selected among the top 20 companies to participate in the prestigious MedTech Innovator Asia Pacific Accelerator 2024 program

We are pleased to share that Qritive was selected among the top 20 companies to participate in the MedTech Innovator Asia Pacific ...

News

Jul 2, 2024

Qritive Receives Award from ISBP-BCRF for Breast Pathology Research at USCAP 2024

Singapore, March 24, 2024 – Qritive, a leading digital pathology company, is pleased to announce its achievement in winning first place...

News

Apr 8, 2024

2 3

NEWS & EVENTS

Qritive at USCAP 2025: Presenting AI-Powered Study on Lymph Node Metastasis Detection

Transforming Laboratory Diagnostics with AI – Qritive at Medlab Middle East 2025

Enhancing Prostate Cancer Diagnosis with AI – Insights from the Uro-oncology Congress

Driving AI Adoption in Pathology Across Europe – Highlights from the 11th Congress

Top Poster Recognition for AI-Powered Diagnostics at Roche’s UK Showcase

Qritive Pte. Ltd. is now ISO/IEC 27001:2022 certified

Qritive selected among the top 20 companies to participate in the prestigious MedTech Innovator Asia Pacific Accelerator 2024 program

Qritive Receives Award from ISBP-BCRF for Breast Pathology Research at USCAP 2024

OUR NEWSLETTERS

Subscribe to our newsletter to get timely updates on latest news and articles.

PARTNER WITH US

We are always looking for partnerships to accelerate development and adoption of AI in pathology.